Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Pergolini
Advanced Age and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Related publications
Effects of Endothelial Dysfunction on Residual Platelet Aggregability After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease
Circulation: Cardiovascular Interventions
Cardiovascular Medicine
Cardiology
Individual Long-Term Variation of Platelet Reactivity in Patients With Dual Antiplatelet Therapy After Myocardial Infarction
Platelets
Medicine
Hematology
Factors Associated With Platelet Reactivity During Dual Antiplatelet Therapy in Patients With Diabetes After Acute Coronary Syndrome
Scientific Reports
Multidisciplinary
Association Between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients With Coronary Artery Disease Undergoing Stent Implantation
Journal of Atherosclerosis and Thrombosis
Biochemistry
Internal Medicine
Cardiovascular Medicine
Cardiology
Long-Term Parallel Tailoring of Dual Antiplatelet Treatment With Acetyl-Salicylic Acid and Clopidogrel in Patients With Acute Myocardial Infarction and High On-Treatment Platelet Reactivity: Impact on Clinical Outcomes
Cardiologia Croatica
Cardiovascular Medicine
Cardiology
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients With Stable Coronary Artery Disease?
Thrombosis and Haemostasis
Hematology
CAR 6. Dual Antiplatelet Therapy and Clopidogrel “Resistance” in Carotid Stenting: Preliminary Results
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Antiplatelet Therapy: Focus on Evidence-Based Therapy With Clopidogrel
Cardiologia Croatica
Cardiovascular Medicine
Cardiology
Comparison of Methods for Monitoring Residual Platelet Reactivity After Clopidogrel by Point-Of-Care Tests on Whole Blood in High-Risk Patients
Thrombosis and Haemostasis
Hematology
